<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Oncopathology</journal-id><journal-title-group><journal-title xml:lang="en">Oncopathology</journal-title><trans-title-group xml:lang="ru"><trans-title>Онкопатология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2618-7019</issn><issn publication-format="electronic">3034-3534</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">708427</article-id><article-id pub-id-type="doi">10.17650/2618-7019-2019-2-1-2-52-67</article-id><article-id pub-id-type="edn">EUYHLP</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Methodical materials and practical recommendations</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Методические материалы и практические рекомендации</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The draft of references on cytomorphological diagnosis of the urinary tract pathology</article-title><trans-title-group xml:lang="ru"><trans-title>ПРОЕКТ РЕКОМЕНДАЦИЙ ПО ЦИТОМОРФОЛОГИЧЕСКОЙ ДИАГНОСТИКЕ ПАТОЛОГИИ УРИНАРНОГО ТРАКТА</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Savostikova</surname><given-names>M. V.</given-names></name><name xml:lang="ru"><surname>Савостикова</surname><given-names>Марина Владимировна</given-names></name></name-alternatives><email>savostikovamv@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kudaybergenova</surname><given-names>A. G.</given-names></name><name xml:lang="ru"><surname>Кудайбергенова</surname><given-names>А. Г.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Fedoseeva</surname><given-names>E. S.</given-names></name><name xml:lang="ru"><surname>Федосеева</surname><given-names>Е. С.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kozorezova</surname><given-names>E. S.</given-names></name><name xml:lang="ru"><surname>Козорезова</surname><given-names>Е. С.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Vorobev</surname><given-names>S. L.</given-names></name><name xml:lang="ru"><surname>Воробьев</surname><given-names>С. Л.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Gorban</surname><given-names>N. A.</given-names></name><name xml:lang="ru"><surname>Горбань</surname><given-names>Н. А.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Central Clinical Hospital, Presidential Administration of Russia</institution></aff><aff><institution xml:lang="ru">ФГБУ «Центральная клиническая больница с поликлиникой» Управления делами Президента Российской Федерации</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">N.N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Петрова» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">National Center of Morphological Diagnostics</institution></aff><aff><institution xml:lang="ru">ООО «Национальный центр клинической морфологической диагностики»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2019-03-07" publication-format="electronic"><day>07</day><month>03</month><year>2019</year></pub-date><volume>2</volume><issue>1-2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>52</fpage><lpage>67</lpage><history><date date-type="received" iso-8601-date="2026-06-09"><day>09</day><month>06</month><year>2026</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2026, ABV-Press</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2026, АБВ-пресс</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="en">ABV-Press</copyright-holder><copyright-holder xml:lang="ru">АБВ-пресс</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://oncopathology.abvpress.ru/2618-7019/about/editorialPolicies</ali:license_ref></license></permissions><self-uri xlink:href="https://oncopathology.abvpress.ru/2618-7019/article/view/708427">https://oncopathology.abvpress.ru/2618-7019/article/view/708427</self-uri><abstract xml:lang="en"><p>A draft of recommendations on cytomorphological diagnosis of the urinary tract pathology is presented. The paper highlights the main points of the pre-analytical stage: the obtaining of the material, its preparation and staining. The categories of the Paris System are presented, the main cytomorphological criteria for assessing the urinary pathology in cytopreparations are noted.</p></abstract><trans-abstract xml:lang="ru"><p>Представлен проект рекомендаций по цитоморфологической диагностике патологии уринарного тракта. В работе освещены основные моменты преаналитического этапа: получение материала, его приготовление и окраска. Представлены категории Парижской классификации 2016 г., отмечены основные цитоморфологические критерии оценки уринарной патологии в цитопрепаратах.</p></trans-abstract><kwd-group xml:lang="en"><kwd>urinary pathology</kwd><kwd>cytological diagnostics</kwd><kwd>Paris System</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>уринарная патология</kwd><kwd>цитологическая диагностика</kwd><kwd>Парижская классификация</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Haber M.H. Pisse prophecy: a brief history of urinalysis. Clin Lab Med 1988;8(3):415-30. PMID: 3048852.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Hughes J.H., Raab S.S., Cohen M.B. The cytologic diagnosis of low-grade transitional cell carcinoma. Am J Clin Pathol (Pathology Patterns Reviews) 2000;114(suppl 1):S59-67. PMID: 11996171.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Long S.R., Cohen M.B. Classics in cytology: V. William Sanders and early urinary tract cytology. Diagn Cytopathol 1992;8:135-6. PMID: 1568411.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Fogazzi G.B., Garigali G. The clinical art and science of urine microscopy. Curr Opin Nephrol Hypertens 2003;12:625-32. PMID: 14564200. DOI: 10.1097/01. mnh.0000098769.18213.39.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Papanicolaou G.N., Marshall V.F. Urine sediment smears as a diagnostic procedure in cancers of the urinary tract. Science 1945;101:519-21. PMID: 17775845. DOI: 10.1126/science.101.2629.519.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Koss L.G., Melamed M.R., Kelly R.E. Further cytologic and histologic studies of bladder lesions in workers exposed to para-aminodiphenyl: progress report. J Natl Cancer Instit 1969;43:233-43. PMID: 5796385.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Murphy W.M., Sloway M.S., Jukkola A.F. et al. Urinary cytology and bladder cancer: the cellular features of transitional cell neoplasms. Cancer 1984;53:1555-65. PMID: 6697294.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Epstein J.I., Amin M.B., Reuter V.R. et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 1998;22:1435-48. PMID: 9850170.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Ferlay J., Soerjomataram I., Dikshit R. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.Int J Cancer 2015;136(5):E359-86. PMID: 25220842. DOI: 10.1002/ijc.29210.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>DeMay R. The art &amp; science of cytopa-thology. 2nd edn. Vol. 1. American Society for Clinical Pathology Press, 2012. P. 437.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Halling K.C., King W., Sokolova I.A. et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol 2000;164:1768-75. PMID: 11025767.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Roshdy M., Hammam O., Abdelsalam A. et al. The Utility of Fluorescence in situ Hybridization for Early Detection of Bladder Urothelial Carcinoma in Comparison with Urine Cytology. Life Sci 2014;11(11):806-11. PMID: 19949672. DOI: 10.3346/jkms.2009.24.6.1139.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Медицинские лабораторные технологии. Под ред. А.И. Карпищенко. T. 1. СПб.: Интермедика, 2002. 408 с.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Миронова И.И., Романова Л.А., Долгов В.В. Общеклинические исследования: моча, кал, ликвор, мокрота. М.: Триада, 2012. С. 5-103.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Стандартизация аналитических технологий лабораторной медицины. Вып. 1. Под ред. В.В. Меньшикова. М.: Лабора, 2012. С. 109-129.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Rosenthal D.L., Wojcik E.M., Kurtycz D.F. The Paris System for Reporting Urinary Cytology. Nw York: Springer, 2016. Pp. 61-74.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Crabtree W.N., Murphy W.M. The value of ethanol as a fixative in urinary cytology. Acta Cytol 1980;24:452-5. PMID: 7001825.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Awad S., Allison S.P., Lobo D.N. The history of 0.9 % saline. Clin Nutr 2008;27:179-88. PMID: 18313809. DOI: 10.1016/j.clnu.2008.01.008.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Pomerat C.M., Overman R.R. Electrolytes and plasma expanders - I. Reaction of human cells in perfusion chambers with phase contrast, time-lapse cine records. Z Zellforsch Mikrosk Anat 1956;45:2-17. PMID: 13402069.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Руководство по цитологической диагностике опухолей человека. Под ред. А.С. Петровой, М.П. Птохова. М.: Медицина, 1976. С. 83.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Gill G.W. Cytopreparation: principles &amp; practice. In: Essentials in cytopathology. Vol. 12. Ed. by D.L. Rosenthal. New York: Springer; 2013. Pp. 73-100.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Amin M.B., Smith S.C., Reuter V.E. et al. Update for the practicing pathologist: The International Consultation On Uro-logic Disease - European association of urology consultation on bladder cancer. Modern Pathology 2014;1:19. PMID: 25412849. DOI: 10.1038/mod-pathol.2014.158.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Galed-Placed I., Valbuena-Ruvira L. Decoy cells and malignant cells coexisting in the urine from a transplant recipient with BK virus nephropathy and bladder adenocarcinoma. Diagn Cytopathol 2011;39:933-7. PMID: 22081531. DOI: 10.1002/dc.21579.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Geetha D., Tong B.C., Racusen L. et al. Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agent. Transplantation 2002;73:1933-6. PMID: 12131691.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Renshaw A.A. Subclassifying atypical urinary cytology specimens. Cancer 2000;90:222-9. DOI: 10.1002/1097-0142(20000825)90: 4%3C222::AID-CNCR4%3E3.0.CO;2-A.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Wojcik E.M. What should not be reported as atypia in urine cytology. J Am Soc Cytopathol 2015;4:30-6. DOI: 10.1016/j. jasc.2014.08.001.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Piaton E., Decaussin-Petrucci M., Mege-Lechevallier F. et al. Diagnostic terminology for urinary cytology reports including the new subcategories "atypical urothelial cells of undetermined significance" (AUC-US) and "cannot exclude high grade"(AUC-H). Cytopathology 2014;25:27-38. PMID: 23461719. DOI: 10.1111/cyt.12050.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Sternberg I., Rona R., Olsfanger S. et al. The clinical significance of class III (suspicious) urine cytology. Cytopathology 2011;22:329-33. PMID: 21114557. DOI: 10.1111/j.1365-2303.2010.00827.x.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>VandenBussche C.J., Sathiyamoorthy S., Owens C.L. et al. The Johns Hopkins Hospital template for urologic cytology samples: parts II and III: improving the predictability of indeterminate results in urinary cytologic samples: an outcomes and cytomorphologic study. Cancer Cytopathol 2013;121:21-8. PMID: 23192913. DOI: 10.1002/cncy.21254.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Ton Nu T.N., Kassouf W., Ahmadi-Kaliji B. et al. The value of the "suspicious for urothelial carcinoma" cytology category: a correlative study of 4 years including 337 patients. Cancer Cytopathol 2014;122:796-803. PMID: 24909774. DOI: 10.1002/cncy.21449.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Renshaw A.A., Nappi D., Weinberg D.S. Cytology of grade 1 papillary transitional cell carcinoma. A comparison of cytologic, architectural and morphometric criteria in cytoscopically obtained urine. Acta Cytol 1996;40:676-82. PMID: 8693885. DOI: 10.1159/000333938.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Barkan G.A., Wojcik E.M., Nayar R. et al. The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized Terminology. Acta Cytol 2016;60:185-97. DOI: 10.1159/000446270.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Raab S.S., Slagel D.D., Jensen C.S. et al. Low-grade transitional cell carcinoma of the urinary bladder: application of select cytologic criteria to improve diagnostic accuracy. Mod Pathol 1996;9:225-32. PMID: 8685219.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Raab S.S., Lenel J.C., Cohen M.B. Low grade transitional cell carcinoma of the bladder. Cytologic diagnosis by key features as identified by logistic regression analysis. Cancer 1994;74:1621-6. PMID: 8062194.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Xin W., Raab S.S., Michael C.W. Low-grade urothelial carcinoma: reappraisal of the cytologic criteria on ThinPrep. Diagn Cytopathol 2003;29:125-9. PMID: 12951678. DOI: 10.1002/dc.10311.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Murphy W.M., Soloway M.S., Jukkola A.F. et al. Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms. Cancer 1984;53:1555-65. PMID: 6697294.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>McCroskey Z., Pambuccian S.E., Kleitherms S. et al. Accuracy and interobserver variability of the cytologic diagnosis of low-grade urothelial carcinoma in instrumented urinary tract cytology specimens. Am J Clin Pathol 2015;144:902-8. PMID: 26572997. DOI: 10.1309/ AJCPE1O9YKMRSQKG.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Nathan N.A., Narayan E., Smith M.M., Horn M.J. Cell block cytology. Improved preparation and its efficacy in diagnostic cytology. Am J Clin Pathol 2000;114:599- 606. PMID: 11026107. DOI: 10.1309/ G035-P2MM-D1TM-T5QE.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Reid M.D., Osunkoya A.O., Siddiqui M.T., Looney S.W. Accuracy of grading of urothelial carcinoma on urine cytology: an analysis of interobserver and intraobserver agreement.Int J Clin Exp Pathol 2012;5:882-91. PMID: 23119105.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Raab S.S., Grzybicki D.M., Vrbin C.M., Geisinger K.R. Urine cytology discrepancies: frequency, causes, and outcomes. Am J Clin Pathol 2007;127:946-53. PMID: 17509992. DOI: 10.1309/XU-VXFXMFPL7TELCE.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Rosenthal D.L., Vandenbussche C.J., Burroughs F.H. et al. The Johns Hopkins Hospital template for urologic cytology samples: part I-creating the template. Cancer Cytopathol 2013;121:15-20. PMID: 23192944. DOI: 10.1002/ cncy.21255.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Ubago J.M., Mehta V., Wojcik E.M., Barkan G.A. Evaluation of atypical urine cytology progression to malignancy. Cancer Cytopathol 2013;121:387-91. PMID: 23536358. DOI: 10.1002/ cncy.21278.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Koss L.G., Hoda R.S. Koss's cytology of the urinary tract with histopathologic correlations. New York: Springer Press, 2012. Pp. 47-71.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Hoda R.S. Non-gynecologic cytology on liquid-based preparations: 3 morphologic review of facts and artifacts. Diagn Cytopathol 2007;35:621-34. PMID: 17854077. DOI: 10.1002/dc.20698.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Khaled H. Schistosomiasis and cancer in Egypt review. J Adv Res 2013;4:461-6. PMID: 25685453. DOI: 10.1016/j. jare.2013.06.007.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Hattori M., Nishimura Y., Toyonaga M. et al. Cytological significance of abnormal squamous cells in urinary cytology. Diagn Cytopathol 2012;40:798-803. PMID: 21309015. DOI: 10.1002/ dc.21645.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Gulmann C., Paner G.P., Parakh R.S. et al. Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract. Hum Pathol 2013;44:164-72. PMID: 22995333. DOI: 10.1016/j.humpath.2012.05.018.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Zhong M., Gersbach E., Rohan S.M., Yang X.J. Primary adenocarcinoma of the urinary bladder: differential diagnosis and clinical relevance. Arch Pathol Lab Med 2013;137:371-81. PMID: 23536017. DOI: 10.1007/s00508-013-0343-1.</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Bardales R.H., Pitman M.B., Stanley M.W et al. Urine cytology of primary and secondary urinary bladder adenocarcinoma. Cancer 1998;34:335-43. PMID: 9915134.</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Ciesla M.C., Guidos B.J., Selvaggi S.M. Cytomorphology of small-cell (neuroendocrine) carcinoma on ThinPrep cytology as compared to conventional smears. Diagn Cytopathol 2001;24:46-52. DOI: 10.1002/1097- 0339(200101)24:1&lt;46:: AID-DC1008&gt;3.0.CO;2-8.</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Dahm P., Gschwend J.E. Malignant non-urothelial neoplasms of the urinary bladder: a review. Eur Urol 2003;44:672-81. PMID: 14644119.</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Chalasani V., Chin J.L., Izawa J.l. Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer. Can Urol Assoc J 2009;3(6 suppl 4): Sl93-8. PMID: 20019984.</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Westfall D.E., Folpe A.L., Paner G.P. et al. Utility of a comprehensive immunohisto-chemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder. Am J Surg Pathol 2009;33:99-105. PMID: 18941404. DOI: 10.1097/ PAS.0b013e318180c899</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Cheson B.D., Schumann J.L., Schumann G.B. Urinary cytodiagnostic abnormalities in 50 patients with non-Hodgkin's lymphomas. Cancer 1984;54:1914-9. PMID: 6478425</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Jimenez-Hernandez M., Lopez-Guillermo A., Cobo F. et al. Bladder involvement of diffuse large B-cell lymphoma diagnosed by a cytological study of the urine. Leuk Lymphoma 2002;43:187-9. PMID: 11908726. DOI: 10.1080/10428190210201</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Khalbuss W.E., Hossain M., Elhosseiny A. Primary malignant melanoma of the urinary bladder diagnosed by urine cytology: a case report. Acta Cytol 2001;45:631-5. PMID: 11480732</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Xiao G.Q., Chow J., Unger P.D. Metastatic tumors to the urinary bladder. Clinicopathologic study of 11 cases. Int J Surg Pathol 2012;20:342-8. PMID: 22134629. DOI: 10.1177/1066896911428736</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Abol-Enein H., Kava B.R., Carmack A.J. Non-urothelial cancer of the bladder. Urology 2007;69(1 suppl):93-104. PMID: 17280911. DOI: 10.1016/j.urology.2006.08.1107</mixed-citation></ref></ref-list></back></article>
